Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
  1. 3/A Insider 3/A
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Chief Scientific Officer acquired 80,000 shares (grant or award)
  4. 4 Grant or award President & CEO acquired 240,000 shares (grant or award)
  5. 4 Grant or award Chief Technology Officer acquired 80,000 shares (grant or award)
  6. 4 Grant or award SVP & Chief Medical Officer acquired 80,000 shares (grant or award)
  7. 4 Grant or award Chief Financial Officer acquired 80,000 shares (grant or award)
  8. 4 Open-market sale President & CEO sold 16,466 shares at $10.53 ($173,443)
  9. 4 Open-market sale Director sold 3,847 shares at $11.16 ($42,919)
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion SVP & Chief Medical Officer acquired 6,983 shares (option exercise)
  12. 4 Open-market sale President & CEO sold 16,466 shares at $12.06 ($198,499)
  13. 4 Open-market sale President & CEO sold 16,466 shares at an average $13.45 ($221,436)
  14. 4 Open-market sale Director sold 8,000 shares at an average $14.09 ($112,746)
  15. 4 Open-market sale Director sold 10,000 shares at an average $13.23 ($132,333)
  16. 4 Open-market sale President & CEO sold 16,466 shares at an average $14.22 ($234,222)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 15 · 288 filings